SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey.
Mohamed Bailor BarrieSulaiman LakohJ Daniel KellyJoseph Sam KanuJames Sylvester SquireZikan KoromaSilleh BahOsman SankohAbdulai BrimaRashid AnsumanaSarah A GoldbergSmit ChitreChidinma OsuagwuRaphael FrankfurterJustin MaedaBernard BarekyeTamuno-Wari NumbereMohammed AbdulazizAnthony MountsCurtis BlantonTushar SinghMohamed SamaiMohamed VandiEugene T RichardsonPublished in: BMJ global health (2021)
Overall seroprevalence was low compared with countries in Europe and the Americas (suggesting relatively successful containment in Sierra Leone). This has ramifications for the country's third wave (which started in June 2021), during which the average number of daily reported cases was 87 by the end of the month:this could potentially be on the order of 3700 actual infections per day, calling for stronger containment measures in a country with only 0.2% of people fully vaccinated. It may also reflect significant under-reporting of incidence and mortality across the continent.